These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex. Rensing N; Han L; Wong M Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303 [TBL] [Abstract][Full Text] [Related]
10. A Human Wundrach D; Martinetti LE; Stafford AM; Bilinovich SM; Angara K; Prokop JW; Crandall SR; Vogt D Front Mol Neurosci; 2020; 13():573409. PubMed ID: 33071758 [TBL] [Abstract][Full Text] [Related]
11. mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus. Schneider M; de Vries PJ; Schönig K; Rößner V; Waltereit R Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):455-463. PubMed ID: 27263037 [TBL] [Abstract][Full Text] [Related]
12. The Stress-Induced Atf3-Gelsolin Cascade Underlies Dendritic Spine Deficits in Neuronal Models of Tuberous Sclerosis Complex. Nie D; Chen Z; Ebrahimi-Fakhari D; Di Nardo A; Julich K; Robson VK; Cheng YC; Woolf CJ; Heiman M; Sahin M J Neurosci; 2015 Jul; 35(30):10762-72. PubMed ID: 26224859 [TBL] [Abstract][Full Text] [Related]
13. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes. Miyazaki M; McCarthy JJ; Esser KA FEBS J; 2010 May; 277(9):2180-91. PubMed ID: 20412061 [TBL] [Abstract][Full Text] [Related]
14. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901 [TBL] [Abstract][Full Text] [Related]
15. mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus. Petrasek T; Vojtechova I; Klovrza O; Tuckova K; Vejmola C; Rak J; Sulakova A; Kaping D; Bernhardt N; de Vries PJ; Otahal J; Waltereit R J Neurodev Disord; 2021 Apr; 13(1):14. PubMed ID: 33863288 [TBL] [Abstract][Full Text] [Related]
16. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259 [TBL] [Abstract][Full Text] [Related]
17. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex. Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598 [TBL] [Abstract][Full Text] [Related]
18. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb. Nobukini T; Thomas G Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760 [TBL] [Abstract][Full Text] [Related]
20. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner. Zou J; Zhang B; Gutmann DH; Wong M Epilepsia; 2017 Dec; 58(12):2053-2063. PubMed ID: 29023667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]